Does imaging αvβ3 integrin expression with PET detect changes in angiogenesis during bevacizumab therapy?

Svetlana N Rylova1, Enikö Barnucz2, Melpomeni Fani3

  • 1German Cancer Consortium (DKTK), Heidelberg, Germany Department of Nuclear Medicine, University Medical Center, Freiburg, Germany German Cancer Research Center (DKFZ), Heidelberg, Germany svetlana.rylova@uniklinik-freiburg.de.

Abstract